Wellington Shields & Co. LLC Takes $190,000 Position in Grail, Inc. (NASDAQ:GRAL)

Wellington Shields & Co. LLC purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 10,662 shares of the company's stock, valued at approximately $190,000.

Other hedge funds have also added to or reduced their stakes in the company. FNY Investment Advisers LLC bought a new position in Grail during the 4th quarter worth $26,000. Lindbrook Capital LLC bought a new position in Grail during the 4th quarter worth $28,000. Wellington Shields Capital Management LLC bought a new position in Grail during the 4th quarter worth $33,000. New York State Common Retirement Fund bought a new position in Grail during the 4th quarter worth $59,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Grail during the 4th quarter worth $64,000.

Insider Buying and Selling

In other Grail news, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the transaction, the president now owns 559,673 shares in the company, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the transaction, the chief financial officer now owns 335,170 shares in the company, valued at approximately $10,457,304. This represents a 0.54 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,550 shares of company stock worth $360,436.

Remove Ads

Analyst Ratings Changes

Separately, Morgan Stanley increased their price objective on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday.

Grail Stock Down 0.6 %

Shares of NASDAQ GRAL traded down $0.17 during mid-day trading on Wednesday, reaching $28.01. The company had a trading volume of 1,158,447 shares, compared to its average volume of 1,223,626. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99. The business's 50-day simple moving average is $32.20 and its 200 day simple moving average is $21.59.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. Sell-side analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.